Cite
HARVARD Citation
Bashir, U. et al. (n.d.). Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model. Nuclear medicine communications. 40 (6), p. . [Online].